Six Months Efficacy and Safety of Aliskiren Therapy on Top of Standard Therapy, on Morbidity and Mortality in Patients With Acute Decompensated Heart Failure
Clinical trial NCT00894387 · COMPLETED
Trial details
- NCT number
- NCT00894387
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2009-05-01
- Primary completion
- 2012-08-01
- Enrollment
- 1639
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.